CA
NZ
UK
AU
IND
US
Tenon Medical moved quickly after receiving a Nasdaq compliance notice earlier this year, securing fresh capital to stave off potential delisting. The medical‑device firm disclosed that it sold $4.2 million of common stock and warrants in a public offering, aiming to meet the exchange’s …
Voyager Therapeutics (NASDAQ: VYGR) has shared new preclinical findings for VY1706, its experimental gene therapy targeting tau protein in Alzheimer’s disease. The results, disclosed at a scientific meeting, suggest the therapy may address a fundamental mechanism underlying disease progression.
Oncolytics Biotech Inc (TSX: ONCY) issued a regulatory notice outlining recent progress within its REO 033 investigation. The notice highlights forthcoming dialogue with U.S. Health regulators and offers investors a concise overview of the program’s status.
Cellectar Biosciences, Inc. (NASDAQ: CLRB) shared the outcomes of its annual shareholders’ meeting, which took place on July 7, 2026. The gathering addressed several key governance and capital‑structure items, reflecting the company’s ongoing efforts to support its growing pipeline in oncology therapeutics.
Dare Bioscience has formally submitted a corporate presentation to regulators, marking a step in its investor communications strategy. The document, dated July 13, 2026.S. Securities and Exchange Commission. This move precedes planned discussions with market participants.
Intuitive Surgical (NASDAQ: ISRG) is reshaping expectations for the healthcare sector as its shares hover about 27% below a $560 target. This discount, combined with a streak of earnings surprises, has drawn attention from investors seeking exposure to medical‑device growth.
The move, effective July 13, 2026, underscores the company’s focus on scaling its antibody discovery platform, which serves pharmaceutical and biotechnology partners. Analysts suggest the hire could signal accelerated growth in OmniAb’s contract research services, a segment increasingly critical for drug development pipelines.
Aethlon Medical Inc. (NASDAQ: AEMD) disclosed new data from its ongoing cancer study, triggering a pre-market rally in its stock. The update highlights early but repeatable immune and tumor-signal shifts observed in the second cohort of participants, reinforcing investor interest in the company’s experimental …
The recent health update from Senator Mitch McConnell has brought attention to the US healthcare sector, as the senator recovers from pneumonia after a fall. This development may impact the sector, particularly in terms of healthcare policy and legislation. The healthcare industry is closely …
Tactile Systems Technology Inc (NASDAQ: TCMD) announced a strategic partnership on July 13, 2026 to expand the reach of its MyoSleeve wearable compression device. The company will serve as the sole U.S.
Please wait processing your request...